Search - tctmd.com

Displaying 61 - 80 of 174

Sort: Relevancy | Date

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

News Conference News ACC 2023

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

Caitlin E. Cox

March 10, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

News Daily News

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Michael O'Riordan

February 22, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

Yael L. Maxwell

September 14, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

Yael L. Maxwell

August 16, 2022

News Daily News

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

Yael L. Maxwell

August 03, 2022

News Daily News

AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death

Caitlin E. Cox

July 22, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

Yael L. Maxwell

June 24, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

Advertisement

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

TCTMD’s Top 10 Most Popular Stories for February 2023

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Only Half of Revascularized PAD Patients Receive GDMT

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death

High Lp(a) May Predict Risk of CV and Limb Events in PAD

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

April 2022 News Roundup

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content